Acta Pharmaceutica, Vol. 69 No. 4, 2019.
Izvorni znanstveni članak
https://doi.org/10.2478/acph-2019-0054
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery
BISERA JURIŠIĆ DUKOVSKI
; University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, 10000 Zagreb, Croatia
ANA BRAČKO
; University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, 10000 Zagreb, Croatia
MARIJA ŠARE
; University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, 10000 Zagreb, Croatia
IVAN PEPIĆ
; University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, 10000 Zagreb, Croatia
JASMINA LOVRIĆ
; University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmaceutical Technology, 10000 Zagreb, Croatia
Sažetak
Oil-in-water nanoemulsions (NEs) represent one of the formulation approaches to improve eye-related bioavailability of lipophilic drugs. The potential of cationic NEs is pronounced due to the electrostatic interaction of positively charged droplets with negatively charged mucins present in the tear film, providing prolonged formulation residence at the ocular surface. The aim of this study was to develop a cationic ophthalmic NE with cationic lipid stearylamine (SA) as a carrier of a positive charge. The addition of a nonionic surfactant provided the dual electro-steric stabilization of NEs and enabled tuning of SA concentration to achieve an optimal balance between its interaction with mucins and biocompatibility. Physicochemical characterization, stability profile, in vitro mucoadhesion study and biocompatibility study employing 3D HCE-T cell-based model of corneal epithelium pointed out the NE with 0.05 % (m/m) SA as the leading formulation. Minimizing SA content while retaining droplet/mucin interactions is of great importance for efficacy and safety of future ophthalmic drug products.
Ključne riječi
cationic nanoemulsions; stearylamine; ophthalmic drug delivery; biocompatibility; mucoadhesion in vitro
Hrčak ID:
225428
URI
Datum izdavanja:
31.12.2019.
Posjeta: 1.739 *